DAIBER ANDREAS,PATEL SANJAYKUMAR,WOERLE HANS-JUERGEN,JOHANSEN ODD-ERIK,KLEIN THOMAS,MARK MICHAEL
申请号：
NZ60922311
公开号：
NZ609223A
申请日:
2011.11.15
申请国别(地区):
NZ
年份:
2016
代理人:
摘要：
Disclosed is the use of linagliptin for treating and/or preventing oxidative stress, vascular stress and/or endothelial dysfunction in a sepsis patient. Also disclosed is use of linagliptin for treating and/or preventing sepsis. In particular the disclosed uses are for patients where sepsis is a complication of diabetes.
